China NMPA Drug Inspection - Daigen Pharmaceutical Co., Ltd. - Cefotetan Hydrochloride for Injection
China NMPA drug inspection for Daigen Pharmaceutical Co., Ltd. published December 28, 2018. Drug: Cefotetan Hydrochloride for Injection. The National Medical Products Administration (NMPA) announced on December 28, 2018, that 18 batches of drugs from 14 com
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Daigen Pharmaceutical Co., Ltd. published December 28, 2018. Drug: Cefotetan Hydrochloride for Injection. The National Medical Products Administration (NMPA) announced on December 28, 2018, that 18 batches of drugs from 14 com
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox